eGFR与白蛋白尿和房颤发病风险的关联:三项队列的荟萃分析
本研究荟萃分析了Jackson心脏研究、多民族动脉粥样硬化研究和心血管健康研究三个前瞻性队列,共16,769名无房颤的参与者。结果显示,eGFR下降和尿白蛋白肌酐比升高均与房颤发病风险显著增加相关,且呈阶梯式上升。调整亚临床心血管疾病及 interim 心衰和心梗后关联仍一致。
要点
- eGFR<30 ml/min/1.73m²者房颤风险是eGFR>90者的2.03倍(95%CI 1.40-2.96)。
- 尿白蛋白肌酐比≥300 mg/g者房颤风险是<15 mg/g者的1.76倍(95%CI 1.18-2.62)。
- 肾功能下降和白蛋白尿与房颤风险的关联独立于亚临床心血管疾病和 interim 心衰/心梗。
核心结论
- eGFR降低和尿白蛋白肌酐比升高均与房颤发病风险显著增加独立相关。
研究设计与样本
- 荟萃分析三个前瞻性队列:Jackson心脏研究、多民族动脉粥样硬化研究和心血管健康研究。
- 纳入16,769名无 prevalent 房颤的参与者,采用Cox回归模型分析。
主要发现
- 随eGFR下降(>90为参照,60-89、45-59、30-44、<30 ml/min/1.73m²),房颤调整风险比分别为1.00、1.09(0.97-1.24)、1.17(1.00-1.38)、1.59(1.28-1.98)、2.03(1.40-2.96)。
- 随尿白蛋白肌酐比升高(<15为参照,15-29、30-299、≥300 mg/g),房颤调整风险比分别为1.00、1.04(0.83-1.30)、1.47(1.20-1.79)、1.76(1.18-2.62)。
- 调整亚临床心血管疾病指标及 interim 心衰和心梗事件后,关联仍一致。
临床怎么用
- 在评估房颤风险时,可考虑将eGFR和尿白蛋白肌酐比作为风险分层指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The incidence of atrial fibrillation is high in ESRD, but limited data are available on the incidence of atrial fibrillation across a broad range of kidney function. Thus, we examined the association of eGFR and urine albumin-to-creatinine ratio with risk of incident atrial fibrillation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We meta-analyzed three prospective cohorts: the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study. Cox regression models were performed examining the association of eGFR and urine albumin-to-creatinine ratio with incident atrial fibrillation adjusting for demographics and comorbidity. In additional analyses, we adjusted for measures of subclinical cardiovascular disease (by electrocardiogram and cardiac imaging) and interim heart failure and myocardial infarction events. RESULTS: In the meta-analyzed study population of 16,769 participants without prevalent atrial fibrillation, across categories of decreasing eGFR (eGFR>90 [reference], 60-89, 45-59, 30-44, and <30 ml/min per 1.73 m2), there was a stepwise increase in the adjusted risk of incident atrial fibrillation: hazard ratios (95% confidence intervals) were 1.00, 1.09 (0.97 to 1.24), 1.17 (1.00 to 1.38), 1.59 (1.28 to 1.98), and 2.03 (1.40 to 2.96), respectively. There was a stepwise increase in the adjusted risk of incident atrial fibrillation across categories of increasing urine albumin-to-creatinine ratio (urine albumin-to-creatinine ratio <15 [reference], 15-29, 30-299, and ≥300 mg/g): hazard ratios (95% confidence intervals) were 1.00, 1.04 (0.83 to 1.30), 1.47 (1.20 to 1.79), and 1.76 (1.18 to 2.62), respectively. The associations were consistent after adjustment for subclinical cardiovascular disease measures and interim heart failure and myocardial infarction events. CONCLUSIONS: In this meta-analysis of three cohorts, reduced eGFR and elevated urine albumin-to-creatinine ratio were significantly associated with greater risk of incident atrial fibrillation, highlighting the need for further studies to understand mechanisms linking kidney disease with atrial fibrillation.
引用
- Bansal N, Zelnick LR, Alonso A, et al. eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study. Clin J Am Soc Nephrol. 2017. PMID: 28798221. doi:10.2215/CJN.01860217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。